Cognitive impairment in the preclinical stage of dementia in FTD-3 CHMP2B mutation carriers: a longitudinal prospective study. (2013)
Attributed to:
Investigation of the mechanism of CHMP2B-induced neurodegeneration using a novel transgenic mouse model
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/jnnp-2012-303813
PubMed Identifier: 23142962
Publication URI: http://europepmc.org/abstract/MED/23142962
Type: Journal Article/Review
Volume: 84
Parent Publication: Journal of neurology, neurosurgery, and psychiatry
Issue: 2
ISSN: 0022-3050